Veristride banner gust 171108
Veristride 20logo 20mark 20 bcrop

Veristride

Veristride's instrumented shoe sensors connect wirelessly with a smartphone and internet to provide real-time feedback/analysis about walking and balance.

  • Stage Full Product Ready
  • Industry Healthcare Services
  • Location Salt Lake City, UT, USA
  • Currency USD
  • Founded July 2012
  • Employees 4
  • Incorporation Type C-corp
  • Website veristride.com

Company Summary

Veristride’s wearable-app-cloud platform (wirelessly) connects our Verialytics (biomechanics/AI) engine on the cloud to sensors on shoes via mobile apps providing feedback to bridge the information gap between clinic and home, with objective data for physical therapists in clinicians and for caregivers/patients in and out of the home.

Team

  • Fred Jaeger, MBA, is a successful serial entrepreneur with expertise in early stage company formation and technology commercialization, university spinouts, IP licensing, govt. contracting. He has raised over $10 million private equity capital, founded and bootstrapped five successful companies; two acquired by publicly traded corporations and others profitably exited in private M&A transactions. BS- chemistry, MBA from Harvard University.

  • Photo
    Founder &CEO

    Dr. Stacy Morris Bamberg is an expert in designing, validating, and using instrumentation to evaluate human physiological conditions, with over a decade experience with insole sensors for gait analysis and real-time feedback. Left faculty position as Assoc. Prof at Univ of Utah to be full-time atVeristride. BSc-ME MIT, MSc-ME MIT, doctorate in Medical Eng. from the Harvard/MIT Division of Health Sciences and Technology.

  • Tim Nieman has over 17 years’ experience as a medical device professional and entrepreneur, with a proven track record of leading and growing businesses. Tim has specialized experience in medical device development, manufacturing, quality, regulatory, and design control, spanning numerous specialties including technologies for cardiac and vascular surgery, stent and catheter based therapies, LVADs, and laser and radiofrequency tissue ablation.

Advisors

Previous Investors

  • Default avatar
    National Science Foundation (SBIR Phase I Jul. 2012, SBIR Phase II Sept. 2013)
    Unconfirmed
    Default avatar
    National Institutes of Health (SBIR Phase I Sept. 2013)
    Unconfirmed
    Default avatar
    State of Utah (Technology Comm. & Innovation Program); Grow Utah Ventures (Concept2Company)
    Unconfirmed